NDC 55566-9700

PREPOPIK

Sodium Picosulfate, Magnesium Oxide, And Anhydrous Citric Acid

PREPOPIK is a Oral Powder, Metered in the Human Prescription Drug category. It is labeled and distributed by Ferring Pharmaceuticals Inc.. The primary component is Sodium Picosulfate; Magnesium Oxide; Anhydrous Citric Acid.

• Product ID: 55566-9700_0717a6b4-73be-4b25-b009-109ac5b8d306
• NDC: 55566-9700
• Product Type: Human Prescription Drug
• Proprietary Name: PREPOPIK
• Generic Name: Sodium Picosulfate, Magnesium Oxide, And Anhydrous Citric Acid
• Dosage Form: Powder, Metered
• Route of Administration: ORAL
• Marketing Start Date: 2014-09-05
• Marketing Category: NDA / NDA
• Application Number: NDA202535
• Labeler Name: Ferring Pharmaceuticals Inc.
• Substance Name: SODIUM PICOSULFATE; MAGNESIUM OXIDE; ANHYDROUS CITRIC ACID
• Active Ingredient Strength: 10 mg/16.2g; g/16.2g; g/16.2g
• Pharm Classes: Increased Large Intestinal Motility [PE],Stimulant Laxative [EPC],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA],Osmotic Laxative [EPC],Osmotic Activity [MoA],Inhibition Small Intestine Fluid/Electrolyte Absorption [PE],Increased Large Intestinal Motility [PE],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2019-12-31

Packaging

NDC 55566-9700-1

2 PACKET in 1 CARTON (55566-9700-1) > 16.2 g in 1 PACKET (55566-9700-0)

• Marketing Start Date: 2014-09-05
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 55566-9700-0 [55566970000]

PREPOPIK POWDER, METERED

• Marketing Category: NDA
• Application Number: NDA202535
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2014-09-05
• Marketing End Date: 2020-05-31

NDC 55566-9700-1 [55566970001]

PREPOPIK POWDER, METERED

• Marketing Category: NDA
• Application Number: NDA202535
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2014-09-05
• Marketing End Date: 2020-05-31

Drug Details

Active Ingredients

Ingredient	Strength
SODIUM PICOSULFATE	10 mg/16.2g

OpenFDA Data

• SPL SET ID: 63e9aeed-31a5-4f22-b3eb-987d38b966f6
• Manufacturer:
  • Ferring Pharmaceuticals Inc.
• UNII:
  • XF417D3PSL
  • 3A3U0GI71G
  • LR57574HN8
• RxNorm Concept Unique ID - RxCUI:
  • 1305808
  • 1305810

Pharmacological Class

• Increased Large Intestinal Motility [PE]
• Stimulant Laxative [EPC]
• Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
• Calculi Dissolution Agent [EPC]
• Magnesium Ion Exchange Activity [MoA]
• Osmotic Laxative [EPC]
• Osmotic Activity [MoA]
• Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]
• Increased Large Intestinal Motility [PE]
• Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
• Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]
• Acidifying Activity [MoA]
• Calculi Dissolution Agent [EPC]
• Anti-coagulant [EPC]
• Decreased Coagulation Factor Activity [PE]
• Calcium Chelating Activity [MoA]

Medicade Reported Pricing

55566970001 PREPOPIK POWDER PACKET

Pricing Unit: EA | Drug Type:

NDC Crossover Matching brand name "PREPOPIK" or generic name "Sodium Picosulfate, Magnesium Oxide, And Anhydrous Citric Acid"

NDC	Brand Name	Generic Name
55566-9300	PREPOPIK	SODIUM PICOSULFATE, MAGNESIUM OXIDE, and ANHYDROUS CITRIC ACID
55566-9700	PREPOPIK	SODIUM PICOSULFATE, MAGNESIUM OXIDE, and ANHYDROUS CITRIC ACID
55566-6700	CLENPIQ	SODIUM PICOSULFATE, MAGNESIUM OXIDE, and ANHYDROUS CITRIC ACID
55566-6800	CLENPIQ	SODIUM PICOSULFATE, MAGNESIUM OXIDE, and ANHYDROUS CITRIC ACID
72032-6700	CLENPIQ	SODIUM PICOSULFATE, MAGNESIUM OXIDE, and ANHYDROUS CITRIC ACID